Loading
companiesCompany
Shanghai Sunway Biotech
Shanghai Sunway Biotech makes Oncorine (H101), the oncolytic adenovirus approved in China in 2005, the first oncolytic virus approved anywhere.
Also called: Sunway Biotech
Overview
Shanghai Sunway Biotech developed and manufactures H101 (Oncorine), an E1B-deleted oncolytic adenovirus approved by China's regulator in November 2005 for late-stage nasopharyngeal carcinoma with chemotherapy. It remains the only approved oncolytic virus in China and is being studied in liver and other cancers.
Headquarters
Shanghai, China, CN
Scorecard
All companies#307of 1244 companies, score 13
- approved products +6
- modalities +2
- regions +1
- registry trials +4
1 approved, 0 in phase 3, 0 earlier, 0 targets, 5 registry studies. Formula on the scorecards page.
Type
Stage
Large private
Website
ApprovedOncolytic virus (E1B-deleted adenovirus)
Oncorine is Shanghai Sunway Biotech's oncolytic adenovirus, approved in China in 2005 for nasopharyngeal carcinoma with chemotherapy, the first oncolytic virus approved anywhere in the world.
Similar pages
- PersonMichael Yu (Yu De-Chao)
Shares Oncolytic viruses and the tag china.
- CompanyJiangsu Hengrui Pharmaceuticals
Shares Nasopharyngeal carcinoma and the tag china.
cancers
technologies
drugs
ApprovedOncolytic virus (E1B-deleted adenovirus)